Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Adma Biologics (ADMA) Accumulated Depreciation & Amortization: 2011-2025

Historic Accumulated Depreciation & Amortization for Adma Biologics (ADMA) over the last 9 years, with Sep 2025 value amounting to $2.0 million.

  • Adma Biologics' Accumulated Depreciation & Amortization rose 5.26% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 3.95%. This contributed to the annual value of $7.7 million for FY2024, which is 1.32% up from last year.
  • As of Q3 2025, Adma Biologics' Accumulated Depreciation & Amortization stood at $2.0 million, which was down 0.00% from $2.0 million recorded in Q2 2025.
  • Adma Biologics' Accumulated Depreciation & Amortization's 5-year high stood at $2.0 million during Q4 2024, with a 5-year trough of $1.1 million in Q1 2021.
  • Moreover, its 3-year median value for Accumulated Depreciation & Amortization was $1.9 million (2025), whereas its average is $1.9 million.
  • Data for Adma Biologics' Accumulated Depreciation & Amortization shows a peak YoY spiked of 83.33% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Adma Biologics' Accumulated Depreciation & Amortization stood at $1.4 million in 2021, then climbed by 28.57% to $1.8 million in 2022, then grew by 5.56% to $1.9 million in 2023, then increased by 5.26% to $2.0 million in 2024, then increased by 5.26% to $2.0 million in 2025.
  • Its last three reported values are $2.0 million in Q3 2025, $2.0 million for Q2 2025, and $1.9 million during Q1 2025.